Is increasing pretreatment HIV drug resistance a real menace or minor detail?

Lancet HIV. 2020 May;7(5):e316-e317. doi: 10.1016/S2352-3018(20)30048-5.

Authors

Seth C Inzaule¹, Raph L Hamers², Silvia Bertagnolio³

Affiliations

¹ Department of HIV/AIDS, World Health Organization, Geneva, Switzerland. Electronic address: [email protected].
² Eijkman-Oxford Clinical Research Unit, Jakarta, Indonesia; Centre for Tropical Medicine and Global Health, Nuffield Dept of Medicine, University of Oxford, Oxford, UK.
³ Department of HIV/AIDS, World Health Organization, Geneva, Switzerland.

PMID: 32386718
DOI: 10.1016/S2352-3018(20)30048-5

No abstract available

Publication types

Letter
Comment

MeSH terms

Drug Resistance, Viral
HIV Infections*
HIV-1*
Humans
Oligonucleotides

Substances

Oligonucleotides